Ke H - Search Results

1

Spondin2 is a new prognostic biomarker for lung adenocarcinoma.

Yuan X, Bian T, Liu J, Ke H, Feng J, Zhang Q, Qian L, Li X, Liu Y, Zhang J. Yuan X, et al. Among authors: ke h. Oncotarget. 2017 Jul 26;8(35):59324-59332. doi: 10.18632/oncotarget.19577. eCollection 2017 Aug 29. Oncotarget. 2017. PMID: 28938639 Free PMC article.

2

Anterior fissureless uniport vs. posterior intra-fissure triple-port thoracoscopic right upper lobectomy: a propensity-matched study.

Ke H, Liu Y, Zhou X, Xue Q. Ke H, et al. J Thorac Dis. 2017 Oct;9(10):3866-3874. doi: 10.21037/jtd.2017.09.61. J Thorac Dis. 2017. PMID: 29268396 Free PMC article.

3

Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy.

Li X, Liu J, Qian L, Ke H, Yao C, Tian W, Liu Y, Zhang J. Li X, et al. Among authors: ke h. Mol Cell Biochem. 2018 Aug;445(1-2):123-134. doi: 10.1007/s11010-017-3258-8. Epub 2018 Jan 11. Mol Cell Biochem. 2018. PMID: 29327288

4

The expression level and prognostic value of HIPK3 among non-small-cell lung cancer patients in China.

Liu Y, Qian L, Yang J, Huang H, Feng J, Li X, Bian T, Ke H, Liu J, Zhang J. Liu Y, et al. Among authors: ke h. Onco Targets Ther. 2018 Oct 25;11:7459-7469. doi: 10.2147/OTT.S166878. eCollection 2018. Onco Targets Ther. 2018. PMID: 30498360 Free PMC article.

5

Association of the SHOX2 and RASSF1A methylation levels with the pathological evolution of early-stage lung adenocarcinoma.

Zhao J, Lu Y, Ren X, Bian T, Feng J, Sun H, Liu L, She B, Liu Y, Ke H. Zhao J, et al. Among authors: ke h. BMC Cancer. 2024 Jun 5;24(1):687. doi: 10.1186/s12885-024-12452-x. BMC Cancer. 2024. PMID: 38840077 Free PMC article.

6

The relationship between EGFR gene mutation status and ERCC1 in lung adenocarcinoma of Chinese patients receiving platinum-based neoadjuvant chemotherapy.

Ke HG, Zhou XY, Shen Y, You QS, Yan Y, Shen ZY. Ke HG, et al. Oncol Res. 2012;20(5-6):221-9. doi: 10.3727/096504013x13589503482897. Oncol Res. 2012. PMID: 23581229

7

Overexpression of RCN1 correlates with poor prognosis and progression in non-small cell lung cancer.

Chen X, Shao W, Huang H, Feng X, Yao S, Ke H. Chen X, et al. Among authors: ke h. Hum Pathol. 2019 Jan;83:140-148. doi: 10.1016/j.humpath.2018.08.014. Epub 2018 Aug 30. Hum Pathol. 2019. PMID: 30172915

8

LncRNA RMRP Promotes Cell Proliferation and Invasion Through miR-613/NFAT5 Axis in Non-Small Cell Lung Cancer.

Yang M, Ke H, Zhou W. Yang M, et al. Among authors: ke h. Onco Targets Ther. 2020 Sep 8;13:8941-8950. doi: 10.2147/OTT.S255126. eCollection 2020. Onco Targets Ther. 2020. PMID: 32982286 Free PMC article.

9

Creation of a Prognostic Risk Prediction Model for Lung Adenocarcinoma Based on Gene Expression, Methylation, and Clinical Characteristics.

Ke H, Wu Y, Wang R, Wu X. Ke H, et al. Med Sci Monit. 2020 Oct 6;26:e925833. doi: 10.12659/MSM.925833. Med Sci Monit. 2020. PMID: 33021972 Free PMC article.

10

Prognostic impact of micropapillary component in patients with node-negative subcentimeter lung adenocarcinoma: A Chinese cohort study.

Yao J, Zhu E, Li M, Liu J, Zhang L, Ke H, Su H, Xie H, Xu G, Zhu L, Fan J, Chen C; Surgical Thoracic Alliance of Rising Star Collaborative Group. Yao J, et al. Among authors: ke h. Thorac Cancer. 2020 Dec;11(12):3566-3575. doi: 10.1111/1759-7714.13702. Epub 2020 Oct 15. Thorac Cancer. 2020. PMID: 33058505 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,547 results

Search Page

Filters